YTEN News and Press, Yield10 Bioscience Inc. From 05/07/21

Gainers: InnSuites Hospitality Trust (IHT) +95%.Regional Health Properties (RHE) +30%.Cooper-Standard (CPS) +25%.MoneyGram International (MGI) +23%.Epizyme (EPZM) +21%.The L.S. Starrett (SCX) +21%.Clene (CLNN) +20%.Yield10 Bioscience (YTEN) +20%.Phio Pharmaceuticals (PHIO) +19%.Core...

WOBURN, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its first quarter 2021 financial results and provide a corporate update on Tuesday, May 11, 2021. Management will ho...

Gainers: Gulf Island Fabrication (GIFI) +15%, Nine Energy Service (NINE) +9%, Olympic Steel (ZEUS) +8%, Universal Stainless & Alloy Products (USAP) +7%, Yield10 Bioscience (YTEN) +7%.Losers: Recon Technology (RCON) -29%, Independence Contract Drilli...

The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with this event. For further details see: Yield10 Bioscience (YTEN) Presents At Benzinga Biotech Small Cap Virtual Conference - Slideshow

WOBURN, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that it will be featured as a presenting company at the Benzinga Biotech Small Cap Conference to be held on March 24-25, 2021 in a virtual f...

The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Yield10 Bioscience, Inc. 2020 Q4 - Results - Earnings Call Presentation

Yield10 Bioscience, Inc. (YTEN) Q4 2020 Earnings Conference Call March 16, 2021 04:30 PM ET Company Participants Lynne Brum – Vice President-Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Snell – Vice President of Resea...

Yield10 Bioscience (YTEN) shares rise more than 10% during post market trading after the company posted a 43% jump in fourth quarter revenue.The company posted Q4 revenue of $0.2M, an increase of 43% from last year, but missed analysts' average estimate by $0.05M.Yield10 said that i...

Yield10 Bioscience (YTEN): Q4 GAAP EPS of -$0.79 misses by $0.09.Revenue of $0.2M (+42.9% Y/Y) misses by $0.05M.Shares +11%.Press Release For further details see: Yield10 Bioscience EPS misses by $0.09, misses on revenue

WOBURN, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended December 31, 2020. "In 2020 we continued to execute our business plan, and successf...